STOCK MARKET BSE NSE

US SEC charges Indian-origin scientist for insider trading

After he learned that his company was about to acquire life sciences company Senquenom, Madan purchased 9,300 shares of Sequenom despite company insider trading policy.

Published: 01st August 2018 08:59 PM  |   Last Updated: 01st August 2018 08:59 PM   |  A+A-

Representational Image. (File | ENS)

By PTI

 

NEW YORK: An Indian-origin scientist has agreed to settle charges that he engaged in insider trading after learning that his company was about to acquire a life sciences company.

Anup Madan, 52, of Washington was a principal scientist with LabCorp's Covance Genomics Laboratory.

The US Securities and Exchange Commission's complaint alleges that Madan learned of the pending acquisition by LabCorp of Sequenom, a Delaware corporation headquartered in San Diego that provides molecular diagnostic testing services, with an emphasis on noninvasive prenatal testing.

Without admitting or denying the allegations, Madan agreed to the entry of a final judgment permanently enjoining him from future violations of the Securities Exchange Act rules.

Madan will disgorge his ill-gotten gains and pay a penalty of USD 14,023, which is equal to the disgorgement amount.

Madan learned of the acquisition when he conducted a due diligence related site visit to Sequenom's San Diego facilities.

Over the next two trading days, Madan purchased 9,300 shares of Sequenom stock despite having signed a company insider trading policy that prohibited trading based upon confidential information that he acquired in the course of performing his job duties.

On the date of the public announcement, Sequenom's stock price increased 176%, allowing Madan to sell his shares that same day for a profit of over USD 14,000.

Stay up to date on all the latest World news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp